Patient Safety Takes the Front Seat

Second Global Ministerial Summit on Patient Safety in Bonn on 29/30 March 2017

Federal Minister of Health Hermann Gröhe ist hosting the Second Global Ministerial Summit on Patient Safety in Bonn on 29/30 March 2017. There is a national consensus among the policy-makers, the medical profession, hospitals and health insurance funds as well as patient groups and industry that safety must be a key theme in taking our health care system further. On the international level, too, awareness of patient safety is rising steadily.

photo: Two women crossing a corridor and a display pointing to the summit

Press photos

Impressions from the Patient Safety Summit 2017

Here you can find press pictures of the Patient Safety Summit on 29/30 March 2017 available to download.

This is why Federal Minister of Health Hermann Gröhe has teamed up with his British counterpart, Jeremy Hunt, to launch an exchange among their opposite numbers around the globe. The immediate result of this initiative was the  in London in the spring of 2016. Now, Federal Minister Hermann Gröhe has invited ministers from more than 50 states and high-ranking representatives of international organisations including the World Health Organization (WHO), World Bank, the OECD and the Council of Europe, to attend the second Ministerial Summit, an event also co-sponsered by WHO.

On the first day, German and international experts, joined by representatives of WHO and OECD, address the current challenges facing patient safety at the former seat of the German Bundestag in Bonn. The workshops will cover a spectrum of topics including the economy and efficiency of patient safety as well as global exchange.

More concrete issues such as mobile health or how to prevent and control infections are also on the agenda. The following day, the ministers and secretaries and their delegations will discuss health policy consequences.

Workshop description

Chair: Dr. Ingo Härtel
Senior Science Advisor, German Federal Ministry of Health, Germany

On the one hand, the aim of the workshop shall be to analyze the economic effects and the efficiency of procedures for the improvement of patient safety at international level. In preparation of this topic, OECD will conduct an international study on economic consequences of patient safety, which is going to regard longer-term and indirect consequences of improved patient safety. On the other hand, the efficiency of patient safety measures will be examined with special attention being paid to safety culture and the influence that leadership style and patients' involvement have in this respect.

Agenda

Economics and Efficiency

  • The Economics of Patient Safety: Strengthening a Value-based Approach to Reducing Patient Harm at National Level – Niek Klazinga, OECD
  • Patient Safety and Implementation Science: New Developments – Jeffrey Braithwaite, Australia

Safety Culture and Leadership

  • Culture and the Economics of Patient Safety – Luke Slawomirski, France
  • Keeping Patients Safe: The Role of Competent Communication – Annegret Hannawa, Switzerland
  • Enhancing Caregiver Resilience: The Role of Staff Support – Albert Wu, USA
  • From Local to National: Compensation Management and the Italian Patient Safety Law – Tommaso Bellandi, Italy

Chair:
Section I: Prof. Sir Liam Donaldson; WHO Envoy for Patient Safety, Geneva, Switzerland
Section II: Dr. Edward Kelley, Director, Service Delivery and Safety Department, WHO, Geneva, Switzerland

Co-Chair:
Dr. Neelam Dhingra-Kumar, World Health Organization, Service Delivery and Safety, Coordinator, Switzerland

This workshop which has been coordinated with WHO will cover international aspects of patient safety. Its main focus will be, inter alia, on strategies that could be implemented in low- and middle-income countries. Moreover, the feasibility to transfer innovative approaches between countries will be discussed. The topics to be examined will include learning, policy & governance as well as leadership.

Agenda

  • Welcome – Sir Liam Donaldson, WHO
  • Objectives and Structure – Neelam Dhingra, WHO
  • Introduction of the Participants – Edward Kelley, WHO

Education, Implementation, Patient and Communities

  • Bringing Transformational Changes in Safety Culture in Hospital Care – Experiences from the Americas – Jonás Gonseth, USA
  • Measuring and Improving Patient Safety in LMIC primary care settings – Experiences from Kenya – Jeremy Veillard, USA
  • Engaging Patients, Families and Communities for Safer and Higher Quality Care – Experiences from Uganda – Regina Kamoga, Uganda
  • Building Competent and Compassionate Health Workforce for Safer Care – Experiences from Thailand – Piyawan Limpanyalert, Thailand

Leadership, Policy, Primary Care

  • Developing Patient Safety Systems – Experiences from Croatia – Jasna Mesaric, Croatia
  • Strengthening Implementation of Patient Safety Policies on Incident Reporting and Learning System – Experience from Malaysia – Nor’Aishah bt Abu Bakar, Malaysia
  • Implementing WHO Safe Childbirth Checklist for Safer Maternal and Neonatal Care – Experiences from Sudan – Ayda Taha, Sudan

Chair: Dr. Mike Durkin, NHS National Director of Patient Safety, United Kingdom

Co-Chair: Prof. Lord Ara Darzi, United Kingdom

Mobile technologies (mHealth, handheld devices) and also technologies to process big datasets (Big Data) are gaining worldwide importance in the field of health, and in a tremendously fast manner. With the aid of mHealth, patient safety may be strengthened, especially by improved patient information and adherence as well as by increasing self-determination. Big Data applications hold the promise of more efficient methods of successful treatment by evidence-based and personalised procedures in health care. Opposed to this are the risks concerning e.g. data safety and product quality. Although patient safety is quoted as the key reason and goal of capital investment in those technologies, the purposeful application and analysis of the latter to reach the established goals of patient safety have not yet been sufficiently developed and networked at international level. In this regard, the workshop is supposed to provide solutions. Against this background, one of the key points of emphasis will be patient safety in connection with non-medical health apps, and attention should be paid to the necessary information of customers/patients, transparency and the role of web stores.

Agenda

New opportunities for patient safety from the use of Big Data and mobile devices

  • Telling apart: Telemedicine, eHealth / mHealth, Big Data Mike Durkin, United Kingdom
  • Protecting Patients and Encouraging Innovation: The Role for Regulation Margaret A. Hamburg, USA
  • Using Artificial Intelligence to Prevent Healthcare Errors from Occurring – Nicolaus Henke, Germany
  • CRAB™: Big Scale – Routine Data as First Alert Ingo Gurcke, Germany
  • Digital Companions for a Sheltered Way: mHealth & Big Data Kurt J.G. Schmailzl, Germany

Mobile Health Apps

  • Bioethical Principles in mHealth and Big Data – Christiane Woopen, Germany
  • What Can Start-ups and Developers Do and What Do They Need to Improve Patient Safety?
     – Peter Langkafel, Germany
  • A. The Vast Amount of Apps for Diabetics – Stephan Kern, Germany
    B. The Model of a Corporative Evaluation of Diabetes-related Apps – a Way to Achieve Better Patient Safety or just another Seal? – Veronika Strotbaum, Germany
    C. What’s helping the users’ choice? – Ilona Köster-Steinebach, Germany
  • Users’ Needs when Confronted with a Product Overflow – Ilona Köster-Steinebach, Germany

Chair: Prof. Dr. Petra Gastmeier
Charité – University Medicine, Head Institute of Hygiene, Germany

Co-Chair:
Prof. Dr. Lindsay Grayson, Australia
Prof. Dr. Martin Mielke, Germany

The central issue of the workshop will be the discussion of measures to prevent infections, in particular in the context of nosocomial infections and sepsis, but also to reduce the use of antibiotics, thus avoiding antimicrobial resistance. On this occasion it shall be examined to which extent national recommendations on infection prevention can also be applied at international level, and particularly in low- and middle-income countries. Along the discussion of strategies for implementing recommendations for action, aspects such as costs incurred by nosocomial infections and the involvement of patients within the scope of infection prevention will be covered.

Agenda

Challenges

  • Impact of Healthcare-associated Infections in Europe: Results of a Population Prevalence-based Modelling Study - Alessandro Cassini, Sweden
  • WHO Core Components for Infection Prevention and Control - Benedetta Allegranzi, Switzerland
  • Implementation of Core Components in a Middle Income Country. What are the most important barriers? - Fernando Otaiza, Chile
  • Implementation of core components in a Low Income Country. What are the most important barriers? - Catherine Cooper, Liberia
  • How to Measure the Degree of Implementation? Establishment of Surveillance Systems, External Assessments vs Self-assessment - Julie Storr, United Kingdom
  • The Special Problem of Sepsis: How to Prevent and Recognize it - Konrad Reinhart, Germany
  • A Nationwide System for Adverse Events Reporting, Accessible to Healthcare Professionals and Patients alike - Christian Brun-Buisson, France

Best Practice

  • A 30-year Sustained National IPC (NIPC) Programme in Chile - Fernando Otaiza, Chile
  • Economic Data and the Control of Healthcare Associated Infection - Nicholas Graves, Australia
  • The Development of a European Surveillance System for HAIs - Carl Suetens, ECDC
  • Strengthening IPC Practices in a Low Resource Setting - Catherine Cooper, Liberia
  • Hand Rub Consumption has almost doubled in 132 German Hospitals over a Period of 9 years – Petra Gastmeier, Germany
  • The Role of Patient Empowerment on Hand Hygiene Compliance - Maryanne McGuckin, USA

Chair: Prof. Dr. Matthias Rothmund
Philipps-University Marburg, Professor of Surgery emeritus, Germany

The key point of emphasis of this workshop will be the topic of safety culture. In this context, examples - as they have been included e.g. in the brochure on best practices which will be published in preparation of the summit - will be used to show in a practice-oriented manner how safe action can be applied in medical care. In addition to international models of success (.e.g. High 5s) and their adaptation to national health care systems, the implementation of checklists, the dissemination of recommendations for action and patients' information as well as the integration of the topic of patient safety in curricula of medical education could be good examples.

Agenda

Patient Safety Culture - Leadership, Education

  • Safety Culture Development as a Core Leadership Responsibility  Tanja Manser, Germany
  • A Practical Approach: Implementation of a Safe Surgery Checklist Patrick Fränkel, Germany
  • Lessons from the Oil and Gas Industry to Improve Patient Safety Abdulelah Alhawsawi, Saudi Arabia
  • Patient Safety Audits based on data provided by Liability Insurers Peter Gausmann, Germany
  • Learning Patient Safety?! – Sonja Barth, Germany

Patient Safety Culture - Patient for Patient, Implementation

  • Involving Patients in the Provision of Safe Care Katja Stahl, Germany
  • Patient Involvement at the Organization Level of Health Care Institutions Solvejg Kristensen, Denmark
  • Patient Safety – Involvement of Patients in Regulation and Governance in Germany – Cordula Mühr, Germany
  • Diagnostic Error: A New Frontier in Patient Safety Victor J. Dzau, USA
  • Participation Promotes Culture! Guenther Jonitz, Germany

Chair: Prof. Dr. Wolf-Dieter Ludwig
Head of Hematology, Oncology and Tumor Oncology, HELIOS Klinikum Berlin-Buch; Member of the Medicines Commissions of the German Medical Association, Germany

The aim of this workshop is to consider safety when dealing with medicinal products with particular regard to demographic change. Especially where the elderly are concerned, medication errors and adverse drug events frequently occur. Therefore, preventive measures shall be discussed above all, as they may help to avoid medication errors among this group of patients, and also the subsequently resulting expenses in the future.

At this workshop, WHO will also announce the global launch of 'WHO Global Patient Safety Challenge – Medication Safety (Medication Without Harm)'.

Agenda

National

  • The German Action Plan for Medication Safety – Wolf-Dieter Ludwig, Germany
  • The German National Medication Plan – Martin Schulz, Germany
  • Medication at Transitions in Care – Cira Kirke, Ireland
  • Critical Success Factors for Medication Safety – Daniel Grandt, Germany
  • New Forms of Risk Communication – Nobert Paeschke, Germany

Global Launch: WHO Global Patient Safety Challenge - Medication Safety

  • Introduction to the Global Patient Safety Challenge on Medication Safety – Sir Liam Donaldson, WHO
  • High-Risk Situations in Medication Safety – Philip A. Routledge, United Kingdom
  • Polypharmacy – Alpana Mair, Scotland
  • Key Causes of Medication Errors and Strategies for Improvement – Allen J. Vaida, USA
  • Medication Safety in Resource-limited Settings – Priyadarshani Galappatthy, Sri Lanka
  • Patient’s Voice for Medication Safety – A Mother’s Perspective – Maryann Murray, Canada 
  • WHO actions on Global Patient Safety Challenge on Medication Safety – Neelam Dhingra-Kumar, WHO
  • Announcement of the “Launch of Global Patient Safety Challenge on Medication Safety” – Sir Liam Donaldson, WHO

Two thirds of the time are reserved in each workshop for the exchange of the participating international experts. Core messages for the briefing of the ministers will be formulated in this debate. The conference languages are English and German.

You can find directions to the venue (World Conference Center Bonn) here.

Downloads